StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Q1-2021 ER Thoughts ..

<< Previous

Bullboard Posts

Next >>

Comment by CashCow23on May 17, 2021 9:19am

88 Views

Post# 33213089

RE:RE:RE:Q1-2021 ER Thoughts ..

Sorry but im new to understanding financial statements... can you help me understand what is Short-Term Portion of Warrant Liability? it seems to be a very high number in the CL and really throwing off their working capital.

Obviouse that is a rhetorical question but shows you how somepeople just try to create a narrative.

In anycase, Tripp needs to be replaces and Stage needs to hire some additional industry help. This isnt going back to 1.6 anytime soon but the case is there if the right steps are taken

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario